24/06/2025
Dear Patients,
Many of you will have seen in the national press that with effect from yesterday, new national rules have come into effect regarding the prescribing of Mounjaro (Tirzepatide) for weight management within GP surgeries.
Only a very small number of patients will qualify for this treatment in a primary care setting due to the very strict eligibility criteria which applies:
- a Body Mass Index of over 40 (or 37.5 if from a minority ethnic background)
- and 4 out of 5 of these conditions: type 2 diabetes, high blood pressure, heart and vascular disease, high cholesterol and obstructive sleep apnoea.
We are currently awaiting further guidance from NHS Sussex; as such, we are not yet in a position to begin prescribing Mounjaro, even in eligible cases.
Once we receive the full details and have reviewed the requirements, we will provide a further update